Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Organic anion transporting polypeptide 1B1 (OATP1B1) is a membrane-bound transporter protein primarily expressed on the basolateral membrane of human hepatocytes. It mediates the sodium-independent facilitated transport of large amphipathic organic anions into liver cells, playing a crucial role in the hepatic uptake of a wide range of endogenous compounds and xenobiotics, including many clinically important drugs. Genetic polymorphisms in SLCO1B1 can significantly alter transporter activity, impacting drug pharmacokinetics and potentially leading to adverse drug reactions or altered efficacy.
Facilitated transport of organic anions across the hepatocyte membrane; inhibition of transport by competing substrates or inhibitors
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Organic Anion Transporting Polypeptide 1B1 (OATP1B1).